The results showed that among adult patients with HFpEF associated with obesity, once-weekly injections of semaglutide 2.4 mg substantially reduced heart failure-related symptoms and physical limitations, and improved exercise function, as well as achieving greater weight loss, compared to placebo
Mimics GLP-1, a naturally occurring hormone produced in your gut that helps regulate blood sugar and your digestive system
Although evidence supporting the use of these medications for alcohol use disorder is growing, the field still needs to learn considerably more about them, particularly in identifying the underlying mechanisms
The coverage landscape shifts frequently, and what is denied today may be approved tomorrow
Recent studies have shown that approximately 74.2% of users report some gastrointestinal symptoms, though it's noteworthy that 47.9% of placebo group participants reported similar issues